Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


1 Am J Clin Pathol
2 Blood
2 BMC Cancer
1 Br J Dermatol
1 Br J Haematol
2 Cancer
1 Cancer Lett
2 Eur J Haematol
1 Haematologica
2 Hum Pathol
1 J Am Acad Dermatol
1 J Clin Oncol
2 Lancet Oncol
1 Oncogene
1 Oncol Rep

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Clin Pathol

  1. WANG Z, Cook JR
    IRTA1 and MNDA Expression in Marginal Zone Lymphoma: Utility in Differential Diagnosis and Implications for Classification.
    Am J Clin Pathol. 2018 Oct 20. pii: 5139642. doi: 10.1093.
    PubMed     Text format     Abstract available


    Cutaneous intralymphatic CD30(+) pseudolymphoma: a reactive condition mimicking lymphoma.
    Blood. 2018;132:1859.
    PubMed     Text format    

  3. KANAAN C, Burroni B
    Unusual location of a follicular lymphoma with features of pediatric-type follicular lymphoma.
    Blood. 2018;132:1725.
    PubMed     Text format    

    BMC Cancer

  4. WU S, Zhou Y, Hua HY, Zhang Y, et al
    Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma.
    BMC Cancer. 2018;18:997.
    PubMed     Text format     Abstract available

  5. SCHELKER RC, Herr W, Reichle A, Vogelhuber M, et al
    Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience.
    BMC Cancer. 2018;18:1000.
    PubMed     Text format     Abstract available

    Br J Dermatol

  6. BONNET P, Battistella M, Bouaziz JD, Ram-Wolff C, et al
    Thymic localization of erythrodermic cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Oct 19. doi: 10.1111/bjd.17340.
    PubMed     Text format     Abstract available

    Br J Haematol

  7. TALAULIKAR D, Biscoe A, Lim JH, Gibson J, et al
    Genetic analysis of Diffuse Large B-cell Lymphoma occurring in cases with antecedent Waldenstrom Macroglobulinaemia reveals different patterns of clonal evolution.
    Br J Haematol. 2018 Oct 18. doi: 10.1111/bjh.15610.
    PubMed     Text format    


  8. BAZARBACHI A, Boumendil A, Finel H, Mohty M, et al
    Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.
    Cancer. 2018 Oct 23. doi: 10.1002/cncr.31755.
    PubMed     Text format     Abstract available

  9. PARKER PA, Banerjee SC, Matasar MJ, Bylund CL, et al
    Efficacy of a survivorship-focused consultation versus a time-controlled rehabilitation consultation in patients with lymphoma: a cluster randomized controlled trial.
    Cancer. 2018 Oct 18. doi: 10.1002/cncr.31767.
    PubMed     Text format     Abstract available

    Cancer Lett

  10. ESPINOZA JL, Matsumoto A, Tanaka H, Matsumura I, et al
    Gastric microbiota: An emerging player in Helicobacter pylori-induced gastric malignancies.
    Cancer Lett. 2018;414:147-152.
    PubMed     Text format     Abstract available

    Eur J Haematol

  11. WOLFF T, Schulz H, Losem C, Reichert D, et al
    Prophylaxis of Chemotherapy-induced Neutropenia and Febrile Neutropenia with Lipegfilgrastim in Patients with Non-Hodgkin Lymphoma (NADIR study).
    Eur J Haematol. 2018 Oct 22. doi: 10.1111/ejh.13189.
    PubMed     Text format     Abstract available

  12. DADA R, Usman B
    Allogeneic hematopoietic stem cell transplantation in r/r Hodgkin lymphoma after treatment with checkpoint-inhibitors: feasibility and safety.
    Eur J Haematol. 2018 Oct 20. doi: 10.1111/ejh.13186.
    PubMed     Text format     Abstract available


  13. BERGMANN AK, Fataccioli V, Castellano G, Martin-Garcia N, et al
    DNA methylation profiling identifies candidate genes for the pathogenesis of hepatosplenic T-cell lymphoma.
    Haematologica. 2018 Oct 18. pii: haematol.2018.196196.
    PubMed     Text format    

    Hum Pathol

  14. ZHANG K, Farrell D, Jeyakumar D, O'Brien S, et al
    Prolymphocytic transformation of Lymphoplasmacytic lymphoma; an extremely unusual event.
    Hum Pathol. 2018 Oct 17. pii: S0046-8177(18)30385.
    PubMed     Text format     Abstract available

  15. LIANG K, Wang J, Wang Y, Zhou Z, et al
    The histological, immunohistochemical and genetic features of classical Hodgkin lymphoma and anaplastic large cell lymphoma with aberrant T-cell/B-cell antigen expression.
    Hum Pathol. 2018 Oct 16. pii: S0046-8177(18)30389.
    PubMed     Text format     Abstract available

    J Am Acad Dermatol

  16. WANG J, Rea B, Haun P, Emerson R, et al
    High-Throughput Sequencing of the T-cell receptor beta chain gene distinguishes two subgroups of cutaneous T-cell lymphoma.
    J Am Acad Dermatol. 2018 Oct 23. pii: S0190-9622(18)32761.
    PubMed     Text format    

    J Clin Oncol

  17. DAVIDS MS, von Keudell G, Portell CA, Cohen JB, et al
    Revised Dose Ramp-Up to Mitigate the Risk of Tumor Lysis Syndrome When Initiating Venetoclax in Patients With Mantle Cell Lymphoma.
    J Clin Oncol. 2018 Oct 25:JCO1800359. doi: 10.1200/JCO.18.00359.
    PubMed     Text format    

    Lancet Oncol

  18. ROBAK T, Jin J, Pylypenko H, Verhoef G, et al
    Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymph
    Lancet Oncol. 2018 Oct 18. pii: S1470-2045(18)30685.
    PubMed     Text format     Abstract available

  19. RULE S
    Bortezomib-based chemotherapy in mantle cell lymphoma.
    Lancet Oncol. 2018 Oct 18. pii: S1470-2045(18)30743.
    PubMed     Text format    


  20. GUO H, Zeng D, Zhang H, Bell T, et al
    Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma.
    Oncogene. 2018 Oct 25. pii: 10.1038/s41388-018-0550.
    PubMed     Text format     Abstract available

    Oncol Rep

  21. HUANG Y, Zou Y, Lin L, Ma X, et al
    miR101 regulates the cell proliferation and apoptosis in diffuse large Bcell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway.
    Oncol Rep. 2018 Oct 24. doi: 10.3892/or.2018.6821.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.